Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results

por Armagan, Berkan, Sari, Alper, Erden, Abdulsamet, Kilic, Levent, Erdat, Efe Cem, Kilickap, Saadettin, Kiraz, Sedat, Bilgen, Sule Apras, Karadag, Omer, Akdogan, Ali, Ertenli, Ihsan, Kalyoncu, Umut
Publicado 2018

How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?

por Sarı, Alper, Şener, Yusuf Ziya, Armağan, Berkan, Kılıç, Levent, Kaya, Ergün Barış, Hekimsoy, Vedat, Karadağ, Ömer, Bilgen, Şule Apras, Kiraz, Sedat, Ertenli, Ali İhsan, Tokgözoğlu, Lale, Akdoğan, Ali
Publicado 2020

Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

por BİLGİN, Emre, CEYLAN, Furkan, DURAN, Emine, FARİSOĞULLARI, Bayram, BÖLEK, Ertuğrul Çağrı, YARDIMCI, Gözde Kübra, KILIÇ, Levent, AKDOĞAN, Ali, KARADAĞ, Ömer, BİLGEN, Şule Apraş, KİRAZ, Sedat, ERTENLİ, Ali İhsan, KALYONCU, Umut
Publicado 2021

Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry

por Duran, Emine, Ozturk, Zeynep Ozge, Bilgin, Emre, Büyükaşık, Yahya, Dizdar, Omer, Yardimci, Gozde Kubra, Farisogullari, Bayram, Özsoy, Zehra, Ayan, Gizem, Uzun, Gullu Sandal, Ekici, Mustafa, Unaldi, Erdinc, Kilic, Levent, Akdoğan, Ali, Karadag, Omer, Bilgen, Şule Apraş, Kiraz, Sedat, Kalyoncu, Umut, Ertenli, Ali Ihsan
Publicado 2023